Change in Growth Differentiation Factor 15, but Not C-Reactive Protein, Independently Predicts Major Cardiac Events in Patients with Non-ST Elevation Acute Coronary Syndrome

Among the numerous emerging biomarkers, high-sensitivity C-reactive protein (hsCRP) and growth-differentiation factor-15 (GDF-15) have received widespread interest, with their potential role as predictors of cardiovascular risk. The concentrations of inflammatory biomarkers, however, are influenced,...

Full description

Saved in:
Bibliographic Details
Main Authors: Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez, Idaira F. Hernandez-Baldomero, Pablo Avanzas, Francisco Bosa-Ojeda
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2014/929536
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568110167621632
author Alberto Dominguez-Rodriguez
Pedro Abreu-Gonzalez
Idaira F. Hernandez-Baldomero
Pablo Avanzas
Francisco Bosa-Ojeda
author_facet Alberto Dominguez-Rodriguez
Pedro Abreu-Gonzalez
Idaira F. Hernandez-Baldomero
Pablo Avanzas
Francisco Bosa-Ojeda
author_sort Alberto Dominguez-Rodriguez
collection DOAJ
description Among the numerous emerging biomarkers, high-sensitivity C-reactive protein (hsCRP) and growth-differentiation factor-15 (GDF-15) have received widespread interest, with their potential role as predictors of cardiovascular risk. The concentrations of inflammatory biomarkers, however, are influenced, among others, by physiological variations, which are the natural, within-individual variation occurring over time. The aims of our study are: (a) to describe the changes in hsCRP and GDF-15 levels over a period of time and after an episode of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) and (b) to examine whether the rate of change in hsCRP and GDF-15 after the acute event is associated with long-term major cardiovascular adverse events (MACE). Two hundred and Fifty five NSTE-ACS patients were included in the study. We measured hsCRP and GDF-15 concentrations, at admission and again 36 months after admission (end of the follow-up period). The present study shows that the change of hsCRP levels, measured after 36 months, does not predict MACE in NSTEACS-patients. However, the level of GDF-15 measured, after 36 months, was a stronger predictor of MACE, in comparison to the acute unstable phase.
format Article
id doaj-art-db598911585e4d4188036ea7f1d3321e
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-db598911585e4d4188036ea7f1d3321e2025-02-03T00:59:50ZengWileyMediators of Inflammation0962-93511466-18612014-01-01201410.1155/2014/929536929536Change in Growth Differentiation Factor 15, but Not C-Reactive Protein, Independently Predicts Major Cardiac Events in Patients with Non-ST Elevation Acute Coronary SyndromeAlberto Dominguez-Rodriguez0Pedro Abreu-Gonzalez1Idaira F. Hernandez-Baldomero2Pablo Avanzas3Francisco Bosa-Ojeda4Department of Cardiology, Hospital Universitario de Canarias, Ofra s/n La Cuesta, 38320 Tenerife, SpainInstituto Universitario de Tecnología Biomédicas, Ofra s/n La Cuesta, 38320 Tenerife, SpainDepartment of Cardiology, Hospital Universitario de Canarias, Ofra s/n La Cuesta, 38320 Tenerife, SpainHospital Universitario Central de Asturias, Area del Corazón, 33006 Oviedo, SpainDepartment of Cardiology, Hospital Universitario de Canarias, Ofra s/n La Cuesta, 38320 Tenerife, SpainAmong the numerous emerging biomarkers, high-sensitivity C-reactive protein (hsCRP) and growth-differentiation factor-15 (GDF-15) have received widespread interest, with their potential role as predictors of cardiovascular risk. The concentrations of inflammatory biomarkers, however, are influenced, among others, by physiological variations, which are the natural, within-individual variation occurring over time. The aims of our study are: (a) to describe the changes in hsCRP and GDF-15 levels over a period of time and after an episode of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) and (b) to examine whether the rate of change in hsCRP and GDF-15 after the acute event is associated with long-term major cardiovascular adverse events (MACE). Two hundred and Fifty five NSTE-ACS patients were included in the study. We measured hsCRP and GDF-15 concentrations, at admission and again 36 months after admission (end of the follow-up period). The present study shows that the change of hsCRP levels, measured after 36 months, does not predict MACE in NSTEACS-patients. However, the level of GDF-15 measured, after 36 months, was a stronger predictor of MACE, in comparison to the acute unstable phase.http://dx.doi.org/10.1155/2014/929536
spellingShingle Alberto Dominguez-Rodriguez
Pedro Abreu-Gonzalez
Idaira F. Hernandez-Baldomero
Pablo Avanzas
Francisco Bosa-Ojeda
Change in Growth Differentiation Factor 15, but Not C-Reactive Protein, Independently Predicts Major Cardiac Events in Patients with Non-ST Elevation Acute Coronary Syndrome
Mediators of Inflammation
title Change in Growth Differentiation Factor 15, but Not C-Reactive Protein, Independently Predicts Major Cardiac Events in Patients with Non-ST Elevation Acute Coronary Syndrome
title_full Change in Growth Differentiation Factor 15, but Not C-Reactive Protein, Independently Predicts Major Cardiac Events in Patients with Non-ST Elevation Acute Coronary Syndrome
title_fullStr Change in Growth Differentiation Factor 15, but Not C-Reactive Protein, Independently Predicts Major Cardiac Events in Patients with Non-ST Elevation Acute Coronary Syndrome
title_full_unstemmed Change in Growth Differentiation Factor 15, but Not C-Reactive Protein, Independently Predicts Major Cardiac Events in Patients with Non-ST Elevation Acute Coronary Syndrome
title_short Change in Growth Differentiation Factor 15, but Not C-Reactive Protein, Independently Predicts Major Cardiac Events in Patients with Non-ST Elevation Acute Coronary Syndrome
title_sort change in growth differentiation factor 15 but not c reactive protein independently predicts major cardiac events in patients with non st elevation acute coronary syndrome
url http://dx.doi.org/10.1155/2014/929536
work_keys_str_mv AT albertodominguezrodriguez changeingrowthdifferentiationfactor15butnotcreactiveproteinindependentlypredictsmajorcardiaceventsinpatientswithnonstelevationacutecoronarysyndrome
AT pedroabreugonzalez changeingrowthdifferentiationfactor15butnotcreactiveproteinindependentlypredictsmajorcardiaceventsinpatientswithnonstelevationacutecoronarysyndrome
AT idairafhernandezbaldomero changeingrowthdifferentiationfactor15butnotcreactiveproteinindependentlypredictsmajorcardiaceventsinpatientswithnonstelevationacutecoronarysyndrome
AT pabloavanzas changeingrowthdifferentiationfactor15butnotcreactiveproteinindependentlypredictsmajorcardiaceventsinpatientswithnonstelevationacutecoronarysyndrome
AT franciscobosaojeda changeingrowthdifferentiationfactor15butnotcreactiveproteinindependentlypredictsmajorcardiaceventsinpatientswithnonstelevationacutecoronarysyndrome